Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Nearly 60 Hair Relaxer Lawsuits Against L’Oréal, Others Consolidated in Illinois Federal Court

At least 57 lawsuits have been filed in federal courts across the country over the products, which use chemicals to permanently straighten textured hair, court records show.
Lawsuits claiming hair relaxer products sold by L'Oréal USA Inc. an other companies cause cancer and other health problems will be consolidated in Chicago federal.
Lawsuits claiming hair relaxer products sold by L'Oréal USA Inc. anD other companies cause cancer and other health problems will be consolidated in Chicago federal court. (Shutterstock)

Nearly 60 lawsuits claiming hair relaxer products sold by L’Oréal USA Inc and other companies cause cancer and other health problems will be consolidated in Chicago federal court, according to a Monday order from the Judicial Panel on Multidistrict Litigation.

At least 57 lawsuits have been filed in federal courts across the country over the products, which use chemicals to permanently straighten textured hair, court records show. The lawsuits allege the companies knew their products contained dangerous chemicals but marketed and sold them anyway.

The actions will be centralised into a multidistrict litigation before U.S. District Judge Mary Rowland, which will streamline discovery efforts and other pretrial issues for the cases, according to the order.

The cases name the US subsidiary of L’Oréal SA and subsidiaries of India-based companies Godrej SON Holdings Inc and Dabur International Ltd. Representatives for the companies, which opposed centralisation of the cases, did not immediately respond to requests for comment.

ADVERTISEMENT

In a statement posted online after the first lawsuits were filed, L’Oréal said it is “confident in the safety of our products and believe the recent lawsuits filed against us have no legal merit.”

The lawsuits follow the October publication of a National Institutes of Health study that found women who used the products multiple times a year were more than twice as likely to develop uterine cancer.

Diandra Debrosse Zimmermann of DiCello Levitt, who filed the first case after the study was published, urged the Judicial Panel on Multidistrict Litigation at a hearing last month to send the cases to Rowland.

Debrosse Zimmermann said the panel’s decision “recognised the clear benefits of centralising the hair relaxer litigation,” adding that she expects many more firms to file their cases in the coming weeks.

She estimates that thousands of women could end up suing over the products, which are typically marketed to women of colour.

By Diana Jones; editing by Leigh Jones

Learn more:

LVMH, L’Oréal Among Suitors for Stake in Aesop

ADVERTISEMENT

Japanese beauty group Shiseido Co. is also studying a potential bid for an interest in Aesop, the people said, asking not to be identified discussing confidential information.


In This Article
Topics

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.

Estée Lauder’s Surprise Acquisition, Explained

The American cosmetic giant’s buyout of Ayurvedic beauty line Forest Essentials came as a surprise. By picking an under-the-radar brand it knows well, the company can show that it’s still in the M&A game without needing to outbid rivals.


view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.

Can Big Luxury Find Its New Look?

Sex sells — if anyone can figure out what sexy means in 2026. Robert Williams tracks the search for a new silhouette at Kering’s Gucci, LVMH’s Dior and more.


VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON